Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom's Disease”

90 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 90 results

Testing effectiveness (Phase 2)Study completedNCT00481871
What this trial is testing

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Who this might be right for
Relapsed or Refractory Lymphoproliferative MalignanciesHodgkin's LymphomaPeripheral T-cell Lymphoma+2 more
Acrotech Biopharma Inc. 119
Testing effectiveness (Phase 2)Study completedNCT00281983
What this trial is testing

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 100
Testing effectiveness (Phase 2)Ended earlyNCT00142168
What this trial is testing

CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 16
Not applicableLooking for participantsNCT05911802
What this trial is testing

Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease

Who this might be right for
Waldenstrom's DiseasePrognostic Index
French Innovative Leukemia Organisation 500
Testing effectiveness (Phase 2)Study completedNCT04463953
What this trial is testing

Zanubrutinib, Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenström Macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Study completedNCT02400437
What this trial is testing

Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00142116
What this trial is testing

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's MacroglobulinemiaLymphoplasmacytic Lymphoma
Steven P. Treon, MD, PhD 25
Early research (Phase 1)Ended earlyNCT01078974
What this trial is testing

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Steven P. Treon, MD, PhD 7
Testing effectiveness (Phase 2)Study completedNCT00005609
What this trial is testing

Rituximab in Treating Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group
Not applicableLooking for participantsNCT04893564
What this trial is testing

Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom's DiseaseWaldenstrom Macroglobulinemia
Centre Hospitalier Universitaire, Amiens 90
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Early research (Phase 1)WithdrawnNCT05176691
What this trial is testing

HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL

Who this might be right for
CLL/SLLNHLMCL+6 more
Hutchmed
Not applicableStudy completedNCT00142155
What this trial is testing

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 300
Testing effectiveness (Phase 2)Ended earlyNCT03679624
What this trial is testing

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; Hypergammaglobulinemia+4 more
Weill Medical College of Cornell University 1
Not applicableActive Not RecruitingNCT01177527
What this trial is testing

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

Who this might be right for
Multiple MyelomaWaldenstrom's MacroglobulinemiaSmoldering Multiple Myeloma+1 more
Dana-Farber Cancer Institute 656
Not applicableEnded earlyNCT05645744
What this trial is testing

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseSmall Lymphocytic Lymphoma, Relapsed+8 more
Mustang Bio 3
Testing effectiveness (Phase 2)Study completedNCT00250926
What this trial is testing

Study of the Combination of Bortezomib, Dexamethasone, and Rituximab in Patients With Waldenstroms Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 23
Not applicableStudy completedNCT03952052
What this trial is testing

Detection of Recurrent Mutations in Waldenström's Disease

Who this might be right for
Waldenstrom's Disease
Centre Henri Becquerel 45
Early research (Phase 1)Ended earlyNCT01744912
What this trial is testing

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+4 more
TG Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Ended earlyNCT02439138
What this trial is testing

Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 5
Load More Results